Cardura
Product Images NDC 0049-2750
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cardura (NDC 0049-2750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 3 (Cardura 02)
The text appears to be a table showing the effectiveness of Cardura in placebo-controlled trials for the treatment of hypertensives with BPH. The trials consisted of titration to a maximum dose of 8mg, a fixed dose of 4mg and 8mg, and a duration of 12 to 14 weeks. The table includes data on maximum flow rate and symptom scores before and after treatment. However, without further context, it is difficult to provide more information or interpretation of the results.*
Figure 1 (Study 1)
Pfizer (Cardura 04)
Cardura 04a
Principal Display Panel (1 mg Tablet Bottle Label)
Principal Display Panel (2 mg Tablet Bottle Label)
Cardura® (doxazosin mesylate) tablets are available in a dosage of 2 mg. Each tablet contains 2 mg of doxazosin mesylate. This product is prescribed medication, and it comes in a bottle containing 100 tablets. The manufacturer is Rosriy, and the distributor is Dison of Pize e in Y, with a zip code of 10017. The NDC number is 004-2760-66. This information is reported on a label or package insert.*
Principal Display Panel (4 mg Tablet Bottle Label)
Principal Display Panel (8 mg Tablet Bottle Label)
This appears to be a description of a medication called "Cardura" which comes in tablet form with a dosage strength of 8mg of doxazosin mesylate. The medication should be stored between 15-30°C (50-86°F). It is meant for prescription use only and each bottle contains 100 tablets. The lot number and expiration date are not available in this text.*
Cardura 09
This is a description of a medication called Cardura (doxazosin) in tablet form. Each tablet contains dorazosin mesyite equivalent to 1 mg doxazosin. It is recommended to store the medication at 25°C with permissible excursions from 15°C to 30°C. The recommended dosage should be seen in the prescribing information. The medication is distributed by the Pfizer division located in NY. The remaining text could not be interpreted.*
Cardura 10
Cardura 11
This is a description for Cardura tablets which are used to treat hypertension and enlarged prostate. The recommended dosage is not available, thus it is necessary to consult the prescription information. Excursions are permitted at temperatures ranging from 16°C to 30°C. The tablets come in a bottle that contains 100 4mg tablets. The drug is distributed by Pfizer Inc and carries the NDG 0049-2614-10 code.*
Cardura 12
This appears to be information regarding the storage and distribution of a prescription medication called Cardura (generic name doxazosin). The medication should be stored at room temperature (25°C or 77°F) and has an NDC ID number of 040:2718:10 with lot number PAA180632. Excursions are permitted at temperatures between 15-30°C (5-86°F). Each bottle contains 100 tablets and it is distributed by Roerig, a division of Pfizer Inc. The prescribing information should be consulted for further details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.